A patient with MRSA is started on daptomycin. Why should lung infections not be treated with this drug?
Show answer and explanation
Correct answer: Inactivation by pulmonary surfactant
Daptomycin is bound and inactivated by surfactant, making it ineffective for pneumonia.
Keep practicing
More Antimicrobials and Resistance questions
- A 7-year-old child is being considered for doxycycline. Why should this drug be avoided?
- A patient treated for TB develops orange urine and elevated LFTs. Which drug is responsible?
- A woman develops a rash after taking ampicillin for a sore throat. She is later diagnosed with mononucleosis. What explains the rash?
- Clavulanic acid is added to amoxicillin to achieve which effect?
- A patient treated with vancomycin for MRSA develops increasing MIC values over time. Which resistance mechanism is most likely?
- A patient on gentamicin develops ototoxicity. Which factor increases this risk?